Another oncogene, polo-like kinase (Plk1), is overexpressed in a wide spectrum of cancers, and correlates with improved survival in specific breast cancer subtypes by causing abnormal chromosome segregation and cytokinesis, which leads to polyploid cells with reduced proliferative potential to inhibit tumor growth [40]. Here, PLK1 is linked to breast carcinoma.